Sanbio
Sanbio's email is info@san-bio.com
and
Sanbio's phone number is 81362643481
.
SanBio is a regenerative medicine company with cell-based products in various stages of research, development, and clinical trials. Its proprietary cell-based product, SB623, is currently in a Phase 2b clinical trial for treatment of chronic motor impairments resulting from stroke with its joint development partner, Sumitomo Dainippon Pharma Co., Ltd., in the United States and Canada. SanBio is also implementing a global Phase 2 clinical trial in the United States and Japan using SB623 for treatment of motor impairment resulting from traumatic brain injury.
View Top Employees for Sanbio
Industry | Biotechnology | |
Location | United States | |
Employees | 20 |
HQ | St. Luke Tower 28F 8-1 Akashi-cho, Chuo-ku | |
Phone | 8136-264-3481 | |
info@san-bio.com | ||
Funding | 48,289,182 USD | |
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
Industry | Biotechnology | |
Location | United States | |
Employees | 20 | |
linkedin.com/company/sanbio | ||
HQ | St. Luke Tower 28F 8-1 Akashi-cho, Chuo-ku | |
Phone | 8136-264-3481 | |
info@san-bio.com | ||
Funding | 48,289,182 USD |
Top Competitors for Sanbio
Sanbio Questions
Where are Sanbio's headquarters?
Sanbio's headquarters are in St. Luke Tower 28F 8-1 Akashi-cho, Chuo-ku
What is Sanbio's phone number?
Sanbio's phone number is 81362643481
How many employees are working in Sanbio right now?
Sanbio has
20 employees.
View the Email and Phone Numbers for all 20 working at Sanbio.
What is Sanbio's industry?
Sanbio's industry is
Biotechnology
Who are Sanbio's top competitors?
Sanbio's top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What is Sanbio's email address?
Sanbio's email address is info@san-bio.com
What are Sanbio's categories?
Sanbio's categories are Agriculture, Biopharma, Biotechnology, Pharmaceutical
What is Sanbio's location?
Sanbio's location is
United States
What is Sanbio's funding?
Sanbio's funding is 48,289,182 USD
What is Sanbio's current status?
Sanbio's current status is ipo